BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Carb-X - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Carb-X
X-ORIGINAL-URL:https://carb-x.org
X-WR-CALDESC:Events for Carb-X
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20220313T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20221106T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20210101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20211031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20221030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20231029T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Rome
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20211031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20221030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Lisbon
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:WEST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:WET
DTSTART:20211031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:WEST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:WET
DTSTART:20221030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:WEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:WET
DTSTART:20231029T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211016
DTEND;VALUE=DATE:20211025
DTSTAMP:20260404T111353
CREATED:20210128T003908Z
LAST-MODIFIED:20210128T003908Z
UID:4919-1634342400-1635119999@carb-x.org
SUMMARY:ICARe Interdisciplinary Course on Antibiotics and Resistance
DESCRIPTION:The emergence and spread of bacteria resistant to many drug classes seriously threaten all branches of modern medicine. There is currently no course providing advanced instruction on antibiotics and resistance. The specific goal of ICARe is to bring leaders in academics and industry together with trained scientists at the dawn of their careers. Cutting-edge approaches for the study of resistance and antibiotic discovery will be examined. \nThe objective of ICARe is to train the next generation of scientists implicated in the study of bacterial resistance to antibiotics and the finding of new drugs.  ICARe is designed for assistant professors\, new industry scientists\, ID fellows\, and postdoctoral research associates\, as well as members from developing areas contending with the challenge of managing antibiotic resistance with limited resources. Attendance will be limited to 40 students and will reflect the global nature of the problem. \nClick here to learn more.\nClick here to view an overview of the programme.
URL:https://carb-x.org/event/icare-interdisciplinary-course-on-antibiotics-and-resistance/
LOCATION:Les Pensieres\, Annecy\, France
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211022
DTEND;VALUE=DATE:20211026
DTSTAMP:20260404T111353
CREATED:20201203T014945Z
LAST-MODIFIED:20210302T211013Z
UID:4719-1634860800-1635206399@carb-x.org
SUMMARY:ID Week 2021
DESCRIPTION:Click here to learn more\, additional details forthcoming. 
URL:https://carb-x.org/event/id-week-2021/
LOCATION:San Diego\, Venue Forthcoming\, CA\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211022T093000
DTEND;TZID=America/New_York:20211022T103000
DTSTAMP:20260404T111353
CREATED:20210819T182315Z
LAST-MODIFIED:20211001T204352Z
UID:5556-1634895000-1634898600@carb-x.org
SUMMARY:CARB-X WEBINAR: European Celebration of 5 Years of Progress with CARB-X
DESCRIPTION:European Celebration of 5 Years of Progress with CARB-X \nA virtual discussion of progress and plans to accelerate innovation globally \n22nd of October\, 2021\, 3:30 – 4:30pm CET / 9:30 – 10:30am ET  \nAntibiotic-resistance undermines the safety net for modern medicine. Chemotherapy\, surgeries\, transplantation\, childbirth – all of these and more depend on antibiotics to treat infection.  At least 700\,000 people die each year due to antibiotic-resistant (AMR) infections\, according to a recent WHO report. A recent Lancet publication from the European Center for Disease Prevention and Control (ECDC) estimates that approximately 33\,000 deaths in the EU each year can be attributed to AMR\, and an Organization of Economic Cooperation & Development OECD report calculates about 1.1 billion Euros are required for the health care systems of EU/EEA countries to address AMR. \nCARB-X and its partners are taking action. CARB-X has funded 92 projects in 12 countries totaling more than $360 million since it launched in 2016. In Europe\, the support of Wellcome Trust\, the German Ministry of Health and Education\, and the UK Global AMR Innovation Fund was critical to this progress over the past five years. \nToday\, the CARB-X portfolio is the world’s largest and most scientifically diverse antibacterial R&D portfolio. We are currently accelerating projects focused on the most serious antibiotic-resistant bacteria\, including new classes of antibiotics and non-traditional agents\, vaccines and other preventatives such as CRISPR-phage\, microbiome-modifying agents and antibodies\, and rapid diagnostics. \nPlease join us for a virtual discussion of the critical role that CARB-X and its global partners play in driving the development of innovative products to address the antibiotic-resistant bacteria health crisis. \nCARB-X Executive Director Kevin Outterson will highlight achievements\, especially in Europe and speak to CARB-X’s future vision and strategy. \nEuropean-based funders of CARB-X will outline their objectives and strategy in preparedness and how CARB-X delivery over 2016-2021 has met some of these goals. \nSeveral European product developers in the current CARB-X portfolio will speak about their innovative products and their experience working with CARB-X. \nA panel of experts will discuss antibiotics as the safety net for modern medicine and the challenges of bringing innovative products to patients in Europe. \n\nVeronika von Messling – Director-General for Life Sciences at the German Federal Ministry of Education and Research (confirmed)\nFlorence Séjourné – Chief Executive Director of Da Volterra and President of BEAM Alliance (confirmed)\nSir Jeremy Farrar – Director of Wellcome Trust & Member of the One Health Global Leaders Group on AMR (confirmed)\n Otto Cars – Founding Director of ReAct\, Senior Professor\, Infectious Diseases\, Uppsala University\, and former member of UN Inter-Agency Coordination Group on AMR (confirmed)\n\nClick here to register\, and to find out more about this important virtual meeting.
URL:https://carb-x.org/event/carb-x-webinar-european-celebration-of-5-years-of-progress-with-carb-x/
LOCATION:WEBINAR\, Webinar\, Webinar\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211024
DTEND;VALUE=DATE:20211027
DTSTAMP:20260404T111353
CREATED:20210128T004706Z
LAST-MODIFIED:20210309T190054Z
UID:4922-1635033600-1635292799@carb-x.org
SUMMARY:World Health Summit
DESCRIPTION:The World Health Summit promotes a science-driven and broad approach to global health development with the Sustainable Development Goals (SDGs) at its core. Our key issues are therefore interdisciplinary\, science-based\, cross-sectoral\, and concerted. They are vital to set the global health agenda for the years to come. Because health is more than medicine and health is a human right. Key issues include: \n\nAccess to Essential Medicine\nBig Data\nBiomedical Research\nClimate Change and Health\nDigital Innovation\nDrugs and Vaccines\nEvolutionary Medicine\nGlobal Action Plan for Healthy Lives and Well-being for All\nGlobal Health Security\nHealth in All Policies\nHealth Systems Strengthening\nPandemic Preparedness\nPatient Safety\nPlanetary Health\nSustainable Development Goals (SDGs)\nTranslational Science\nUniversal Health Coverage\n\nClick here to learn more.
URL:https://carb-x.org/event/world-health-summit/
LOCATION:Berlin\, Germany
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211103
DTEND;VALUE=DATE:20211105
DTSTAMP:20260404T111353
CREATED:20210128T004148Z
LAST-MODIFIED:20210518T183536Z
UID:4920-1635897600-1636070399@carb-x.org
SUMMARY:BARDA Industry Day
DESCRIPTION:BARDA Industry Day is the annual meeting held to increase potential partner’s awareness of U.S. Government medical countermeasure priorities\, interact with BARDA and ASPR staff\, and network with public and private sector colleagues working in the Health Security space. \nAdditional details forthcoming.
URL:https://carb-x.org/event/barda-industry-day-3/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211108
DTEND;VALUE=DATE:20211110
DTSTAMP:20260404T111353
CREATED:20201203T015107Z
LAST-MODIFIED:20211101T152552Z
UID:4720-1636329600-1636502399@carb-x.org
SUMMARY:World Antimicrobial Resistance Congress 2021
DESCRIPTION:Antimicrobial resistance (AMR) is one of the biggest global health crises facing the world today. The number of deaths attributed to AMR is expected to surpass the number of deaths from cancer worldwide by 2050. Yet combatting resistance globally and developing a robust arsenal of antibiotics continues to fall behind the pace of resistance.\nSince 2015\, the World Anti-Microbial Resistance Congress has been the go-to conference globally for all stakeholders in the AMR space to meet\, brainstorm ideas and formulate initiatives that can effectively tackle this pressing issue. \nIndustry leaders\, innovative technology and solution providers\, public authorities\, international organizations\, infectious disease clinicians\, pharmacists and microbiologists are some of the 1\,000+ attendees from over 50 countries who will gather this November 2021 at the World Anti-Microbial Resistance Congress. \nThe conference will gather global leaders in infectious diseases to meet\, brainstorm and discuss the challenges and opportunities on the following areas: \n\nAdvancing antibiotic R&D and non-traditional therapies development\nEnhancing the commercial landscape and marketplace for antibiotics and diagnostics\nDeveloping innovative diagnostics solutions\nFacilitating interactions between funders and developers\nImproving antimicrobial stewardship guidelines and practice through technology\nImplementing sustainable environmental and manufacturing practices\nTackling infection control at hospitals efficiently and cost-effectively\nApplying genomics to easily detect resistant pathogens and to accelerate antibiotic R&D\nLeveraging surveillance platforms and solutions to monitor outbreaks and increasing numbers of resistant pathogens locally\, regionally\, nationally and globally.\n\nIf you work in these key areas of AMR\, then you must attend the World Anti-Microbial Resistance Congress 2021! \nClick here to learn more.\nClick here to view the agenda.\nClick here to register.
URL:https://carb-x.org/event/world-amr-congress-2021/
LOCATION:Washington DC
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211114
DTEND;VALUE=DATE:20211119
DTSTAMP:20260404T111353
CREATED:20210128T002137Z
LAST-MODIFIED:20210128T002137Z
UID:4907-1636848000-1637279999@carb-x.org
SUMMARY:9th ASM Conference on Biofilms
DESCRIPTION:The 9th ASM Conference on Biofilms will be coming to Charlotte\, N.C. on Nov. 14 –18\, 2021.  Additional Details Forthcoming. \nBiofilms have a tremendous impact on industrial\, clinical and natural environments. 2021 ASM Biofilms will provide an interdisciplinary platform to discuss the latest biofilm research. Check back later for more details about the meeting. We look forward to seeing you next year. \nClick here to learn more.\nClick here to view the agenda.
URL:https://carb-x.org/event/9th-asm-conference-on-biofilms/
LOCATION:Charlotte\, North Carolina
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211115
DTEND;VALUE=DATE:20211117
DTSTAMP:20260404T111353
CREATED:20210127T235230Z
LAST-MODIFIED:20210127T235230Z
UID:4908-1636934400-1637107199@carb-x.org
SUMMARY:3rd SCI-RSC Symposium on Antimicrobial Drug Discovery
DESCRIPTION:At a time when antimicrobial resistance is decreasing the efficacy of existing treatments\, it has never been more important that we refresh the drug pipeline with new therapeutics acting on new targets or exhibiting novel modes of action.\nFortunately\, renewed interest from both industry and academia has led to a resurgence in antimicrobial drug discovery and interest in developing innovative technologies and approaches for combating infection. \nCoinciding with WHO’s World Antibiotics Awareness week\, this two-day meeting will examine the latest advances in antimicrobial drug discovery from a medicinal chemist’s perspective\, focusing on the particular challenges associated with developing antimicrobials whilst also showcasing emerging strategies for tackling infection. \nBringing together leading exponents in the field from industry and academia\, the meeting will appeal to anyone with an interest in antimicrobial resistance and antimicrobial drug discovery. And with great opportunities for academic–industrial partnerships\, researchers from both sectors will also benefit from the networking opportunities that the meeting will offer. \nClick here to learn more.\nEmail conferences@soci.org to register your interest. \nConference Team\nTel: +44 (0)20 7598 1561\nEmail: conferences@soci.org
URL:https://carb-x.org/event/3rd-sci-rsc-symposium-on-antimicrobial-drug-discovery/
LOCATION:SCI\, 14/15 Belgrave Square\, London\, SW1X 8PS\, United Kingdom
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211116T080000
DTEND;TZID=America/New_York:20211116T093000
DTSTAMP:20260404T111353
CREATED:20211014T205847Z
LAST-MODIFIED:20211014T205847Z
UID:5629-1637049600-1637055000@carb-x.org
SUMMARY:EFPIA - Pandemic Prevention: how Europe can lead the fight against AMR
DESCRIPTION:You’re invited to join this virtual event on Tuesday\, 16 November\, 2021 at 14:00 – 15:30 CET. \nThe COVID-19 pandemic took the world by surprise. An AMR induced pandemic will not.\nThe World Bank estimates that 10 million people per year could die if new antimicrobials are not found. Without effective prevention and treatment of infections\, medical procedures such as organ transplantation\, cancer chemotherapy\, and major surgery will become too dangerous to perform. In the Pharmaceutical Strategy for Europe\, the European Commission declared that “new business models are required” if we are to meet this challenge and succeed\, spotlighting 2022 as the year when change needs to happen.\n\nJoin us to discuss how we can drive investment in antimicrobials R&D and set out a roadmap to a sustainable innovation ecosystem that will safeguard society against the threat of AMR.\n  \nCARB-X participants include Kevin Outterson\, Executive Director. \nClick here to learn more and register.
URL:https://carb-x.org/event/efpia-pandemic-prevention-how-europe-can-lead-the-fight-against-amr/
LOCATION:VIRTUAL EVENT
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211119T140000
DTEND;TZID=America/New_York:20211119T150000
DTSTAMP:20260404T111353
CREATED:20211026T161854Z
LAST-MODIFIED:20211026T161854Z
UID:5639-1637330400-1637334000@carb-x.org
SUMMARY:McGill AMR Innovation Summit
DESCRIPTION:Antimicrobials in the era of AMR\nDuring World Antimicrobial Awareness Week (Nov. 18-24 2021)\, the McGill AMR Centre and Innovation + Partnership office are hosting the inaugural McGill AMR Innovation Summit\, a virtual event aimed at discussing antimicrobial R&D and building collaborations and partnerships between McGill scientists and non-academic stakeholders. \nProgram\n\n14:00-14:30 Keynote speaker Erin Duffy\, PhD (public event)\n14:30-15:00 Panel discussion (public event)\n15:00-16:00 Industry-Academic networking event (private event)\n\nKeynote speaker Erin Duffy\, PhD\, Chief of R&D\, CARB-X\nCARB-X is a global non-profit partnership dedicated to accelerating antibacterial research to tackle the global rising threat of drug-resistant bacteria. With up to US$480 million to invest in 2016-22\, CARB-X portfolio is the world’s largest early development pipeline in AMR. \nPanel discussion Challenges and opportunities for antimicrobial R&D in the era of AMR\nWith experts from industry and academia. \n• David Claveau\, PhD\, Director\, Medical Affairs at AVIR Pharma\n• Erin Duffy\, PhD\, Chief of Research & Development\, CARB-X\n• Joseph Mancini\, PhD\, Head of Pharmacology and Biologics\, Senior Director at adMare BioInnovations\n• Nicolas Moitessier\, PhD\, Professor in Chemistry (McGill)\, co-founder of Molecular Forecaster\n• Martin Schmeing\, PhD\, Professor in Biochemistry (McGill)\, Director of Centre for Structural Biology\n• Christopher Tan\, PhD\, Director\, Business Development & Licensing\, Search & Evaluation\, Infectious Diseases & Vaccines at Merck Research Laboratories \nRegistration is free but required. \nIf you have any questions\, please contact us at amrcentre@mcgill.ca \nClick here to learn more.\nClick here to register.
URL:https://carb-x.org/event/mcgill-amr-innovation-summit/
LOCATION:VIRTUAL EVENT
ORGANIZER;CN="McGill University":MAILTO:amrcentre@mgcill.ca
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211123T070000
DTEND;TZID=America/New_York:20211123T080000
DTSTAMP:20260404T111353
CREATED:20211118T193239Z
LAST-MODIFIED:20211118T193420Z
UID:5664-1637650800-1637654400@carb-x.org
SUMMARY:AMR Industry Alliance Panel on Supporting the Optimal Use of Antimicrobial Medicines through Innovation
DESCRIPTION:This year’s WAAW will take place 18-24 November 2021\, with the theme “Spread Awareness\, Stop Resistance”. You can read more about WHO’s WAAW campaign here. \nThe AMR Industry Alliance virtual panel session will be organized as short dialogues among experts from the public\, private\, academic and civil society sectors who will discuss key topics related to the optimal use of antimicrobial medicines as a means of controlling the spread of antimicrobial resistance (AMR). \nThe three short dialogues will focus on the following topics: \n\nThe role of diagnostics in guiding optimal use of antibiotics\nRelevance of AMR stewardship in achieving the UN SDGs\nStop resistance! Collaborative approaches to tackling AMR\n\nSpeakers include: \n\nHanan H. Balkhy\, Assistant-Director-General\, AMR\, WHO\nThomas Cueni\, Chair\, AMR Industry Alliance & Director-General\, IFPMA\nOtridah Kapona\, National AMR Focal Point and Coordinator\, Zambia National Public Health Institute\, WHO STAG-AMR\nCecilia Ferreyra\, Head of AMR Programme\, FIND\nMukesh Kapila\, Global Health and Humanitarian Affairs\, University of Manchester\, WHO STAG-AMR\nLiz Tayler\, Team Leader\, Monitoring and National Action Plans AMR\, WHO\nScott Weese\, Professor\, Ontario Veterinary College and Director\, Centre for Public Health and Zoonoses\, University of Guelph\nKevin Outterson\, Executive Director\, CARB-X\nPilar Ramon Pardo\, AMR Advisor\, PAHO\nPeter Beyer\, Senior Advisor and Team Lead\, AMR\, WHO\nJean-Louis Tissier\, Vice-President\, Public and Government Affairs\, BioMérieux\nAdam Zerda\, Director\, AMR Strategy and Program Development\nGreg Frank\, Director\, Global Public Policy\, Merck\n\nClick here to learn more.\nClick here to register.
URL:https://carb-x.org/event/amr-industry-alliance-panel-on-supporting-the-optimal-use-of-antimicrobial-medicines-through-innovation/
LOCATION:VIRTUAL EVENT
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211208
DTEND;VALUE=DATE:20211210
DTSTAMP:20260404T111353
CREATED:20211116T181031Z
LAST-MODIFIED:20211116T181031Z
UID:5654-1638921600-1639094399@carb-x.org
SUMMARY:ASM/ESCMID Joint Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance
DESCRIPTION:The 2021 ASM/ESCMID Joint Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance will take place online\, Dec. 8-9\, 2021.  \n\n\nAntimicrobial drug resistance (AMR) is an urgent global health problem. New antimicrobial drug development is increasingly viewed as a priority by national and international bodies. Co-sponsored by the American Society for Microbiology (ASM) and the European Society for Clinical Microbiology and Infectious Diseases (ESCMID)\, this multidisciplinary meeting will address the challenges\, opportunities and current requirements for antimicrobial drug development to address antimicrobial resistance.\n\n\n\nClick here to learn more.\nClick here to view the agenda.\nClick here to register.
URL:https://carb-x.org/event/asm-escmid-joint-conference-on-drug-development-to-meet-the-challenge-of-antimicrobial-resistance/
LOCATION:VIRTUAL EVENT
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211209
DTEND;VALUE=DATE:20211211
DTSTAMP:20260404T111353
CREATED:20210920T181851Z
LAST-MODIFIED:20210920T181851Z
UID:5588-1639008000-1639180799@carb-x.org
SUMMARY:Infection 2021: British Society for Antimicrobial Chemotherapy (BSAC) Winter Conference
DESCRIPTION:Join us as we celebrate 50 years of BSAC! Infection 2021 is an exciting two-day hybrid conference looking at the challenges and future of infection management and how we can rise the meet the challenge of antimicrobial resistance. \nWe encourage you to register for either in-person or virtual attendance and submit your abstracts for consideration for oral and poster presentation.  All accepted abstracts will be published in JAC-Antimicrobial Resistance. \nCARB-X participants include Kevin Outterson\, Executive Director\, who will be leading the session “The potential of de-linkage in addressing antimicrobial resistance” on Friday December 10th. \nClick here to learn more.\nClick here to view the agenda.
URL:https://carb-x.org/event/infection-2021-british-society-for-antimicrobial-chemotherapy-bsac-winter-conference/
LOCATION:VIRTUAL EVENT
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211216
DTEND;VALUE=DATE:20211218
DTSTAMP:20260404T111353
CREATED:20210127T234756Z
LAST-MODIFIED:20210127T234907Z
UID:4909-1639612800-1639785599@carb-x.org
SUMMARY:ICAAR 2021: 15. International Conference on Antibiotics and Antibiotic Resistance - Bangkok\, Thailand
DESCRIPTION:The International Research Conference is a federated organization dedicated to bringing together a significant number of diverse scholarly events for presentation within the conference program. Events will run over a span of time during the conference depending on the number and length of the presentations. With its high quality\, it provides an exceptional value for students\, academics and industry researchers. \nICAAR 2021: 15. International Conference on Antibiotics and Antibiotic Resistance aims to bring together leading academic scientists\, researchers and research scholars to exchange and share their experiences and research results on all aspects of Antibiotics and Antibiotic Resistance. It also provides a premier interdisciplinary platform for researchers\, practitioners and educators to present and discuss the most recent innovations\, trends\, and concerns as well as practical challenges encountered and solutions adopted in the fields of Antibiotics and Antibiotic Resistance \nClick here to learn more.\nClick here to view the agenda.\nClick here to register.
URL:https://carb-x.org/event/icaar-2021-15-international-conference-on-antibiotics-and-antibiotic-resistance-bangkok-thailand/
LOCATION:Bangkok\, Thailand
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Asia/Kolkata:20220203T180000
DTEND;TZID=Asia/Kolkata:20220203T190000
DTSTAMP:20260404T111353
CREATED:20220201T201308Z
LAST-MODIFIED:20220201T201420Z
UID:5820-1643911200-1643914800@carb-x.org
SUMMARY:Stewardship can accelerate efforts to combat AMR
DESCRIPTION:CARB-X Compliance Manager\, Rose Garson\, will join Taslimarif Saiyed\, PhD of Centre for Cellular and Molecular Platforms (C-CAMP) to speak on the role that stewardship and access play in combating #AMR. \n✏️ Register: https://bit.ly/3o3op9B
URL:https://carb-x.org/event/stewardship-can-accelerate-efforts-to-combat-amr/
LOCATION:VIRTUAL EVENT
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20220204T170000
DTEND;TZID=Europe/London:20220204T183000
DTSTAMP:20260404T111353
CREATED:20220121T152052Z
LAST-MODIFIED:20220121T152359Z
UID:5771-1643994000-1643999400@carb-x.org
SUMMARY:Global Research on Antimicrobial Resistance (GRAM) Virtual Event
DESCRIPTION:The GRAM report was published in The Lancet on 20 January 2022. The online launch event will explore these compelling new findings on the global burden of AMR and regional patterns and trends for over 88 pathogen-drug combinations; celebrate the global collaboration and 100’s of data partnerships that made this study possible; consider how data can be harnessed to support governments\, health systems and civil society to act and reduce the human-cost of AMR; and identify immediate actions that can help countries around the world protect their health systems against the threat of AMR. \nConfirmed speakers include: \n\nProfessor Chris Murray\, Director of the Institute for Health Metrics and Evaluation\nDame Sally Davies\, UK Special Envoy on AMR\nDr Hanan Balkhy\, Assistant Director General for Antimicrobial Resistance\, World Health Organization\nDr Richard Horton\, Editor-in-Chief of The Lancet\n\nIf you can join live register here. Places are limited so please register early to avoid disappointment. \nIf you cannot join live\, but would like to receive the recording\, please request the post-event recording here and a link to the recording will be sent once available. Please note a recording will also be shared with those joining live. \nThe GRAM project is a collaboration led by Institute for Health Metrics and Evaluation and the University of Oxford and was funded by the Fleming Fund\, the Bill & Melinda Gates Foundation and Wellcome Trust. \nIf you have any queries\, please email GlobalEvents@wellcome.org
URL:https://carb-x.org/event/global-research-on-antimicrobial-resistance-gram-virtual-event/
LOCATION:VIRTUAL EVENT
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220226
DTEND;VALUE=DATE:20220228
DTSTAMP:20260404T111353
CREATED:20220120T221325Z
LAST-MODIFIED:20220120T223058Z
UID:5754-1645833600-1646006399@carb-x.org
SUMMARY:Gordon Research Seminar: Biology of Acute Respiratory Infection (GRS)
DESCRIPTION:Host-pathogen interactions during pulmonary health and disease \nThe Gordon Research Seminar on Biology of Acute Respiratory Infection is a unique forum for graduate students\, post-docs\, and other scientists with comparable levels of experience and education to present and exchange new data and cutting-edge ideas. \nChairs: Anukul T. Shenoy and Kristin M. Noell
URL:https://carb-x.org/event/gordon-research-seminar-biology-of-acute-respiratory-infection-grs/
LOCATION:Four Points Sheraton / Holiday Inn Express\, 1050 Schooner Drive\, Ventura\, CA\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220227
DTEND;VALUE=DATE:20220305
DTSTAMP:20260404T111353
CREATED:20220120T221008Z
LAST-MODIFIED:20220120T222513Z
UID:5751-1645920000-1646438399@carb-x.org
SUMMARY:Gordon Research Conference: Biology of Acute Respiratory Infection
DESCRIPTION:Basic Mechanisms and Translational Science Contributing to the Global Impact of Pneumonia \nThe 2022 Gordon Research Conference on the Biology of Acute Respiratory Infections will center on biological events dictating pneumonia outcome and the degree to which these events have been or could be leveraged by clinical practice. This will benefit from integrated contributions across multiple disciplines\, including but not limited to immunologists\, microbiologists\, and clinicians\, resulting in a venue that uniquely assembles the world’s foremost experts in pneumonia research. In this way\, the 2022 GRC on the Biology of Acute Respiratory Infection and the associated Gordon Research Seminar will cultivate an opportunity for creative and multidisciplinary discussions for this rapidly evolving area of investigation\, maximizing the potential for innovative discoveries and clinical interventions. \nChairs: Lee J. Quinton and Stephania Cormier\nVice Chairs: Bethany B. Moore and Charles Dela Cruz
URL:https://carb-x.org/event/gordon-research-conference-biology-of-acute-respiratory-infection/
LOCATION:Four Points Sheraton / Holiday Inn Express\, 1050 Schooner Drive\, Ventura\, CA\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20220303T140000
DTEND;TZID=Europe/London:20220303T160000
DTSTAMP:20260404T111353
CREATED:20220121T143743Z
LAST-MODIFIED:20220121T152643Z
UID:5766-1646316000-1646323200@carb-x.org
SUMMARY:The Longitude Prize: AMR& Diagnostic Frontiers: Developing and increasing access to innovative diagnostics in and for low-and-middle-income countries (LMICs)
DESCRIPTION:Are you developing AMR diagnostics in or for an LMIC? Or do you have a product that could be adapted and tested for use in low resource settings? \nPitch your technology and get customer-driven feedback from a panel of global health representatives at the virtual event with FIND\, the global alliance for diagnostics and CARB-X. \nRegister to pitch your product. Visit the Longitude Prize website for more information and to sign-up to the event.
URL:https://carb-x.org/event/the-longitude-prize-amr-diagnostic-frontiers-developing-and-increasing-access-to-innovative-diagnostics-in-and-for-low-and-middle-income-countries-lmics/
LOCATION:VIRTUAL EVENT
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220305
DTEND;VALUE=DATE:20220307
DTSTAMP:20260404T111353
CREATED:20201203T015353Z
LAST-MODIFIED:20201203T015646Z
UID:4721-1646438400-1646611199@carb-x.org
SUMMARY:Gordon Research Seminar: New Antibacterial Discovery and Development
DESCRIPTION:The chair is currently developing a description for this conference. This information will be available by May 5\, 2021. Please check back for updates. \nClick here to learn more.\nClick here to register.
URL:https://carb-x.org/event/gordon-research-conference/
LOCATION:Renaissance Tuscany Il Ciocco\, Via Giovanni Pascoli\, Lucca (Barga)\, 55051\, Italy
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220305
DTEND;VALUE=DATE:20220307
DTSTAMP:20260404T111353
CREATED:20210128T002555Z
LAST-MODIFIED:20210128T002652Z
UID:4918-1646438400-1646611199@carb-x.org
SUMMARY:Gordon Research Seminar: New Antibacterial Discovery and Development (GRS)
DESCRIPTION:The chair is currently developing a description for this conference. This information will be available by May 5\, 2021. Please check back for updates. \nClick here to learn more.\nClick here to view the agenda.\nClick here to register.
URL:https://carb-x.org/event/gordon-research-seminar-new-antibacterial-discovery-and-development-grs/
LOCATION:Renaissance Tuscany Il Ciocco\, Via Giovanni Pascoli\, Lucca (Barga)\, 55051\, Italy
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220306
DTEND;VALUE=DATE:20220312
DTSTAMP:20260404T111353
CREATED:20201203T015702Z
LAST-MODIFIED:20201203T015716Z
UID:4722-1646524800-1647043199@carb-x.org
SUMMARY:Gordon Research Conference: New Antibacterial Discovery and Development
DESCRIPTION:Applications for this meeting must be submitted by February 6\, 2022. Please apply early\, as some meetings become oversubscribed (full) before this deadline. If the meeting is oversubscribed\, it will be stated here. Note: Applications for oversubscribed meetings will only be considered by the conference chair if more seats become available due to cancellations. \nClick here to learn more.\nClick here to register.
URL:https://carb-x.org/event/gordon-research-conference-new-antibacterial-discovery-and-development/
LOCATION:Renaissance Tuscany Il Ciocco\, Via Giovanni Pascoli\, Lucca (Barga)\, 55051\, Italy
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220401
DTEND;VALUE=DATE:20220402
DTSTAMP:20260404T111353
CREATED:20210621T183744Z
LAST-MODIFIED:20210621T183744Z
UID:5462-1648771200-1648857599@carb-x.org
SUMMARY:BactiVac 3rd Annual Network Meeting
DESCRIPTION:Further to the postponement of our 3rd Annual Network Meeting in Kenya 24-27 March 2020\, we have constantly been reviewing the global situation surrounding COVID-19. As a Network focusing on global health our priority must continue along the lines of taking the required precautions to minimize the spread of the virus. Our commitment to deliver this meeting continues and it is the intention to host this event in Kenya in Spring 2022. \nFurther details on the exact timing of the event and Programme will be provided in due course. \nClick here to learn more.
URL:https://carb-x.org/event/bactivac-3rd-annual-network-meeting/
LOCATION:Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220407
DTEND;VALUE=DATE:20220409
DTSTAMP:20260404T111353
CREATED:20220401T202634Z
LAST-MODIFIED:20220401T202634Z
UID:5924-1649289600-1649462399@carb-x.org
SUMMARY:AMR Conference
DESCRIPTION:The AMR Conference is a platform for subject matter experts (SMEs)\, start-ups\, big pharma\, academia\, investors and public institutions to discuss strategies and the specific challenges in bringing new antimicrobial treatments and diagnostics to the market.
URL:https://carb-x.org/event/amr-conference/
LOCATION:Congress Center Basel\, Messepl. 21\, Basel\, 4058\, Switzerland
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220418
DTEND;VALUE=DATE:20220424
DTSTAMP:20260404T111353
CREATED:20220120T223737Z
LAST-MODIFIED:20220120T223737Z
UID:5762-1650240000-1650758399@carb-x.org
SUMMARY:18th International Conference on Pseudomonas
DESCRIPTION:The conference promotes academic and social collaborations among all scientists in the research fields of Pseudomonas – the genus that contains human\, animal and plant pathogens as well as biocontrol agents.
URL:https://carb-x.org/event/18th-international-conference-on-pseudomonas-2/
LOCATION:Georgia Tech Hotel and Conference Center\, 800 Spring St. NW\, Atlanta\, GA\, 30308\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220423
DTEND;VALUE=DATE:20220427
DTSTAMP:20260404T111353
CREATED:20201203T015955Z
LAST-MODIFIED:20201203T015955Z
UID:4723-1650672000-1651017599@carb-x.org
SUMMARY:ECCMID 2022
DESCRIPTION:Click here to learn more\, additional details forthcoming. 
URL:https://carb-x.org/event/eccmid-2022/
LOCATION:ALTICE ARENA\, Rossio dos Olivais\, Lote 2.13.01 A\, Lisbon\, 1990-231\, Portugal
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220427
DTEND;VALUE=DATE:20220430
DTSTAMP:20260404T111353
CREATED:20220122T011134Z
LAST-MODIFIED:20220122T011134Z
UID:5778-1651017600-1651276799@carb-x.org
SUMMARY:Wellcome Connecting Science: Antimicrobial Resistance – Genomes\, Big Data and Emerging Technologies (Virtual Conference)
DESCRIPTION:This year’s program will include antimicrobial discovery and global trends in AMR\, in addition to the focus on genomic evidence and the other tools for surveillance. It will highlight the recent advances in the rapidly emerging field of machine learning and GWAS methods to predict AMR. We will also discuss the role of vaccines in AMR\, diagnostics\, and how to translate the research findings into clinical practice and policy. \nThis conference will bring together basic researchers\, clinicians\, computer scientists\, and policymakers interested in pathogen genomics\, epidemiology and surveillance\, machine learning\, as well as the development of novel diagnostic and therapeutic tools and approaches.
URL:https://carb-x.org/event/wellcome-connecting-science-antimicrobial-resistance-genomes-big-data-and-emerging-technologies-virtual-conference/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220609
DTEND;VALUE=DATE:20220614
DTSTAMP:20260404T111353
CREATED:20201203T020158Z
LAST-MODIFIED:20201203T020158Z
UID:4724-1654732800-1655164799@carb-x.org
SUMMARY:ASM Microbe 2022
DESCRIPTION:ASM Microbe connects you to a global network of scientists\, researchers and health care professionals. Whether it’s presenting your research to peers and luminaries in your field\, or accessing the latest science and novel techniques in your area or related discipline\, ASM Microbe is the premier forum to share knowledge and collaborate across the full spectrum of microbiology. Take advantage of the meeting’s interactive learning formats to build a customized experience across 8 scientific tracks. \nASM Microbe 2022 | June 9–13\, 2022 • Washington\, D.C.\nASM Microbe 2023 | June 15–19\, 2023 • Houston\, Texas\nASM Microbe 2024 | June 13–17\, 2024 • Atlanta\, Ga.\nASM Microbe 2025 | June 19–23\, 2025 • Los Angeles\, Calif. \nClick here to learn more.
URL:https://carb-x.org/event/asm-microbe-2022/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220609T090000
DTEND;TZID=America/New_York:20220609T093000
DTSTAMP:20260404T111353
CREATED:20220519T110012Z
LAST-MODIFIED:20220519T122004Z
UID:6155-1654765200-1654767000@carb-x.org
SUMMARY:Public Webinar: How CARB-X Partners are Addressing the Global Health Threat of AMR
DESCRIPTION:A 30-minute public webinar will be held on June 9\, 2022 at 09:00 AM EDT with representatives from CARB-X\, BARDA\, Wellcome and NIAID to discuss the global health issues of AMR\, and how CARB-X and its partners are working together to address them. \nThe webinar celebrates a recent funding announcement in which BARDA and Wellcome have committed up to an additional US$370 million to CARB-X. \nRegister in advance to attend:\nhttps://bostonu.zoom.us/meeting/register/tJcvde6grjIjGNNROqfFhs5d6RSiOirgYin9
URL:https://carb-x.org/event/2022-carb-x-public-webinar-amr/
LOCATION:VIRTUAL EVENT
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220623T090000
DTEND;TZID=America/New_York:20220623T120000
DTSTAMP:20260404T111353
CREATED:20220525T203315Z
LAST-MODIFIED:20220525T204305Z
UID:6208-1655974800-1655985600@carb-x.org
SUMMARY:Global Vaccine and Immunization Research Forum
DESCRIPTION:Topic:\nVaccines as Tools to Prevent Antimicrobial Resistance: Advances\, Challenges and Future Development \nPurpose:\nAntimicrobial resistance caused 4.95 million deaths associated with AMR and 1.27 million deaths attributable to AMR in 2019. Vaccines can prevent a proportion of the AMR burden by preventing drug-sensitive and drug-resistant infections\, reducing antibiotic use and reducing pathogen transmission and chances of developing resistance genes. Increasing evidence from observational and modelling studies show the impact of vaccines on AMR. \nHowever\, this evidence is yet to translate to policy and decision making about which vaccines to develop and introduce\, so they effectively prevent AMR. This webinar will explore the mechanisms\, evidence and value of vaccines in preventing AMR. A panel of experts will discuss the challenges to ensure that vaccines to prevent AMR are developed and widely used. \nRegistration:\nhttps://who.zoom.us/webinar/register/WN_Iudu_2LtRIqv6hA6IkCkBQ \nAudience\nScientists\, product developers\, regulators\, policy makers\, implementers and funders interested in the role of vaccines in preventing AMR. \nTopics \n\nThe threat of AMR and ways through which vaccines can prevent it;\nAssessment of the value of vaccines in preventing AMR;\nResearch priorities on vaccines and AMR;\nDevelopment pipeline for vaccines against AMR priority pathogens;\nThe role of vaccines in National Action Plans on AMR;\nStories from the field: how vaccines were used in Zimbabwe to prevent AMR;\nChallenges and opportunities to ensure that vaccines against AMR are developed and used.\n\nAbout GVIRF\nThe Global Vaccine and Immunization Research Forum\, the central forum for research related to Immunization Agenda 2030\, brings together the entire vaccine and immunization research community every two years and is organized by the U.S. National Institute of Allergy and Infectious Diseases\, the Bill & Melinda Gates Foundation\, and the World Health Organization. Between biennial meetings\, a series of webinars is also organized to address emerging issues of interest.
URL:https://carb-x.org/event/global-vaccine-and-immunization-research-forum/
LOCATION:VIRTUAL EVENT
END:VEVENT
END:VCALENDAR